In certain embodiments, any controlled release otic formulation or composition described herein increases the exposure of a therapeutic agent and increases the Area Under the Curve (AUC) in otic fluids (e.g., endolymph and/or perilymph) by about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, or about 90% compared to a formulation or composition that is not a controlled release otic formulation or composition
Ipamorelin and GHRP-2 work together to stimulate GH production while minimizing side effects like hunger spikes
Another proposed mechanism for platinum drug resistance is the formation of adducts between the platinum drug and the cysteinyl-glycine product of GT
131 Other data indicate that depletion of single amino acids such as methionine is sufficient for hepatic FGF21 production
Ryan AS, Egan JM, Habener JF, Elahi D